The Centre of Excellence for Prevention of Organ Failure:医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C10290)
◆英語タイトル:The Centre of Excellence for Prevention of Organ Failure - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10290
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
The Centre of Excellence for Prevention of Organ Failure (PROOF Centre) is a healthcare center that provides blood-based biomarker tests. The center conducts biomarker programs to develop simple blood tests for transplant patients and patients with chronic organ disease and biomarkers in transplantation, chronic kidney disease, and others. It offers services such as chronic obstructive pulmonary disease, chronic heart failure, acute heart failure, recovered organ failure, and others. PROOF Centre provides blood-based biomarker tests for the prevention, diagnosis and treatment of heart, lung and kidney failure, among others. The center caters its clients across Canada. PROOF Centre is headquartered in Vancouver, British Columbia, Canada.

The Centre of Excellence for Prevention of Organ Failure – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment Deals By Type, 2012 to YTD 2018 6
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deal Details 10
Partnerships 10
HTG Molecular Diagnostics Enters Into Licensing Agreement With Centre of Excellence for Prevention of Organ Failure For COPD Prognostic Test 10
PROOF Centre Partners with AstraZeneca 11
Proof Centre Enters Into Co-Development Agreement With HTG Molecular Diagnostics 12
Proof Centre Enters Into Co-Development Agreement With AllerGen For Allergy Biomarkers 13
Proof Centre Enters Into Co-Development Agreement With IO Informatics 14
OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 15
Centre of Excellence for Prevention of Organ Failure Enters Into Co-Development Agreement With Adiga Life Sciences For Proteomic And Genomic Biomarkers 16
The Centre of Excellence for Prevention of Organ Failure – Key Competitors 17
The Centre of Excellence for Prevention of Organ Failure – Key Employees 18
The Centre of Excellence for Prevention of Organ Failure – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Key Facts 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment Deals By Type, 2012 to YTD 2018 6
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
The Centre of Excellence for Prevention of Organ Failure, Deals By Market, 2012 to YTD 2018 8
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
HTG Molecular Diagnostics Enters Into Licensing Agreement With Centre of Excellence for Prevention of Organ Failure For COPD Prognostic Test 10
PROOF Centre Partners with AstraZeneca 11
Proof Centre Enters Into Co-Development Agreement With HTG Molecular Diagnostics 12
Proof Centre Enters Into Co-Development Agreement With AllerGen For Allergy Biomarkers 13
Proof Centre Enters Into Co-Development Agreement With IO Informatics 14
OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 15
Centre of Excellence for Prevention of Organ Failure Enters Into Co-Development Agreement With Adiga Life Sciences For Proteomic And Genomic Biomarkers 16
The Centre of Excellence for Prevention of Organ Failure, Key Competitors 17
The Centre of Excellence for Prevention of Organ Failure, Key Employees 18

List of Figures
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ The Centre of Excellence for Prevention of Organ Failure:医療機器:M&Aディール及び事業提携情報(The Centre of Excellence for Prevention of Organ Failure - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆